-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 29, the official website of NMPA showed that the first domestic posaconazole injection developed by Jiangsu Osaikang Pharmaceutical Co.
NMPA pictures
1.
1.
The enteric-coated tablet type has higher bioavailability than suspension, higher blood concentration, and is not affected by diet and the PH value of the digestive tract, and has a better preventive effect.
In addition to preventive indications, posaconazole also shows great potential in the treatment of invasive aspergillosis.
Today, the posaconazole injection independently developed by Osaikang Pharmaceutical has also been approved, which makes up for the disadvantages of oral dosage forms used in ICU patients and patients during transplantation.
It is reported that, in order to benefit more patients, the company will fund the foundation to carry out the Aisuan® nationwide patient assistance program.
2.
2.
Source: 2020 Financial Report of Osaikang Pharmaceutical